Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Tranexamic acid (TA) inhibits fibrinolysis by binding to lysine binding-sites of plasminogen to fibrin. Fibrinolysis is stimulated by surgical trauma, and the administration of TA has been shown effective in decreasing blood loss both intra-operatively and in the immediate post-operative period in elective hip and knee arthroplasty patients. Both the timing and dosing of TA has been investigated in these patients. Subsequent blood transfusion rate has also been shown to decrease as result of TA administration. Despite the support for TA utilization that exists in the arthroplasty literature, the data is scarce regarding its administration during surgical treatment of hip fractures. This is patient population who is at high risk for transfusion due to symptomatic post-operative anemia. This study aims to investigate whether TA's advantageous effects in the arthroplasty patient population can be extrapolated to the more unstable, heterogeneous hip fracture patient population. If the study is able to show a difference in blood loss and transfusion requirement, the long term implications of this with regards to cost and mortality can be significant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2014
CompletedFirst Posted
Study publicly available on registry
April 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedApril 14, 2016
April 1, 2016
February 10, 2014
April 8, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
calculation of blood loss during the perioperative period
This study aims to investigate the effect of tranexamic acid (TA) on blood loss and transfusion requirement during the perioperative period in patients who are admitted to the hospital with fracture of the hip and undergo surgical treatment. Both the drop in hemoglobin level from time of surgery (T0 being defined as just prior to surgery, while the patient waits in surgical holding area) over the subsequent several days, as well as post-operative transfusion rate, will be measured. The researchers' hypothesis is that both the hemoglobin drop and the subsequent transfusion requirement in patients who receive TA will be less than those who received saline placebo.
participants will be followed for the duration of hospital stay, an expected average of 2-3 days
Study Arms (2)
Control
PLACEBO COMPARATORInterventional
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients admitted to Bryn Mawr Hospital with fracture of the femoral neck, intertrochanteric region, or subtrochanteric region of the femur will be considered for the study.
You may not qualify if:
- age under 18
- allergy to TA
- known current or history of venous thromboembolism (VTE)
- history of known coagulopathy or bleeding disorder
- current subarachnoid hemorrhage
- previous history of seizures
- current use of estrogen/progesterone therapy
- renal failure defined as creatinine clearance less than 30 ml/min4
- multiple fractures
- pregnant or breastfeeding women
- planned nonoperative management of the fracture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, 19010, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2014
First Posted
April 14, 2016
Primary Completion
February 1, 2017
Last Updated
April 14, 2016
Record last verified: 2016-04